Exagen (XGN) Asset Utilization Ratio (2019 - 2025)
Historic Asset Utilization Ratio for Exagen (XGN) over the last 7 years, with Q3 2025 value amounting to 1.05.
- Exagen's Asset Utilization Ratio fell 1282.41% to 1.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.05, marking a year-over-year decrease of 1282.41%. This contributed to the annual value of 1.09 for FY2024, which is 4915.6% up from last year.
- Latest data reveals that Exagen reported Asset Utilization Ratio of 1.05 as of Q3 2025, which was down 1282.41% from 1.19 recorded in Q2 2025.
- In the past 5 years, Exagen's Asset Utilization Ratio registered a high of 1.33 during Q1 2025, and its lowest value of 0.35 during Q2 2021.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.74 (2023), whereas its average is 0.76.
- As far as peak fluctuations go, Exagen's Asset Utilization Ratio plummeted by 2746.2% in 2021, and later skyrocketed by 9673.74% in 2023.
- Quarter analysis of 5 years shows Exagen's Asset Utilization Ratio stood at 0.38 in 2021, then increased by 26.18% to 0.49 in 2022, then surged by 83.77% to 0.89 in 2023, then soared by 41.36% to 1.26 in 2024, then dropped by 16.99% to 1.05 in 2025.
- Its last three reported values are 1.05 in Q3 2025, 1.19 for Q2 2025, and 1.33 during Q1 2025.